Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 417,550 | 399,685 | 406,387 | 413,343 | 382,477 |
| Cost of Goods | 190,013 | 181,990 | 182,113 | 180,586 | 166,933 |
| Gross Profit | 227,537 | 217,695 | 224,274 | 232,757 | 215,544 |
| Operating Expenses | 153,757 | 151,774 | 152,492 | 145,040 | 143,674 |
| Operating Income | 73,793 | 66,911 | 71,895 | 88,303 | 72,803 |
| Interest Expense | 8,304 | 7,926 | 7,750 | 7,259 | 6,304 |
| Other Income | 820 | 800 | 684 | 559 | 425 |
| Pre-tax Income | 66,309 | 59,785 | 64,829 | 81,603 | 66,924 |
| Income Tax | 20,284 | 15,395 | 20,600 | 24,665 | 20,346 |
| Net Income Continuous | 46,025 | 44,390 | 44,229 | 56,938 | 46,578 |
| Minority Interests | 6 | 41 | 6 | 26 | -16 |
| Net Income | $46,019 | $44,349 | $44,223 | $56,912 | $46,594 |
| EPS Basic Total Ops | 0.51 | 0.49 | 0.48 | 0.61 | 0.49 |
| EPS Basic Continuous Ops | 0.51 | 0.49 | 0.48 | 0.61 | 0.49 |
| EPS Diluted Total Ops | 0.51 | 0.48 | 0.48 | 0.60 | 0.49 |
| EPS Diluted Continuous Ops | 0.51 | 0.48 | 0.48 | 0.60 | 0.49 |
| EBITDA(a) | $92,339 | $85,105 | $91,145 | $105,093 | $88,957 |